Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 26, 1999Arthritis Research & TherapyOpen Access

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis

View Full Paper
Ask AI
Bookmark
Share

Authors

Leo A. B. Joosten
Leo A. B. JoostenUniversity of North Carolina at Chapel HillELErik LubbertsErasmus MCMHM. Helsen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Joosten et al. (1999) studied this question.

synapsesocial.com/papers/6a9992cf94826fd4daa5f57ehttps://doi.org/10.1186/ar14
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CARTILAGE OLIGOMERIC MATRIX PROTEIN: A NOVEL MARKER OF CARTILAGE TURNOVER DETECTABLE IN SYNOVIAL FLUID AND BLOOD1992 · 348 citations
  2. 2Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts.1991 · 267 citations
  3. 3Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes1990 · 458 citations
  4. 4Dual role of IL-12 in early and late stages of murine collagen type II arthritis1997 · 147 citations
  5. 5Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-41993 · 988 citations